BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND STAT5B, STAT5, 6777, ENSG00000173757, P51692
994 results:

  • 1. Hyperactive stat5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
    Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
    J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ponatinib and stat5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid leukemia Cells.
    Tezcanli Kaymaz B; Gumus N; Celik B; Alcitepe İ; Biray Avci C; Aktan C
    J Interferon Cytokine Res; 2024 Apr; 44(4):178-189. PubMed ID: 38579140
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
    Hou Z; Ren Y; Zhang X; Huang D; Yan F; Sun W; Zhang W; Zhang Q; Fu X; Lang Z; Chu C; Zou B; Gao B; Jin B; Kang Z; Liu Q; Yan J
    Cell Commun Signal; 2024 Apr; 22(1):211. PubMed ID: 38566191
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways].
    Fan C; Zhang Y; Yang R; Wu X; Zhou J; Xue J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations.
    Wang Z; Lu X; Liu C; Huang F; Lu T; Chen Y; Liu L; Lu S
    Eur J Med Chem; 2024 Mar; 268():116237. PubMed ID: 38387337
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. stat5 is essential for inducing the suppressive subset and attenuate cytotoxicity of Vδ2
    Cheng C; Liang S; Yue K; Wu N; Li Z; Dong T; Dong X; Ling M; Jiang Q; Liu J; Huang XJ
    Cancer Lett; 2024 Apr; 587():216730. PubMed ID: 38360140
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
    Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
    Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/stat5 signalling pathways and sensitivity to TKI in ph-like ALL.
    Xu GF; Zeng Z; Zhang ZB; Zhang XM; Wang M; Xiao Q; Li J; Xie XQ; He S; Fu HH; Liu Y; Yang ZL; Chen Y; Shi J; Wang B; Qiu HY; Zhou Q; Liu Y; Chen SN
    J Cell Mol Med; 2024 Feb; 28(3):e18114. PubMed ID: 38323741
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation.
    Lee JK; Chatterjee A; Scarpa M; Bailey CM; Niyongere S; Singh P; Mustafa Ali MK; Kapoor S; Wang Y; Silvestri G; Baer MR
    Cancer Res Commun; 2024 Feb; 4(2):431-445. PubMed ID: 38284896
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia.
    Chen Z; Wang Q; Yan YY; Jin D; Wang Y; Zhang XX; Liu XH
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2305852. PubMed ID: 38258519
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of concurrent STAT3::RARA and RARA::stat5b fusions in a variant APL case.
    Tao T; Cen J; Xu C; Chen Y; Cao Y; Gong Y; Zhu M; Chen S; Zhang Q; Yao L
    Mol Carcinog; 2024 Apr; 63(4):558-562. PubMed ID: 38153216
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia.
    Li Y; Seet CS; Mack R; Joshi K; Runde AP; Hagen PA; Barton K; Breslin P; Kini A; Ji HL; Zhang J
    Stem Cell Reports; 2024 Jan; 19(1):100-111. PubMed ID: 38101400
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML.
    Zhang X; Zhang K; Zhang J; Chang W; Zhao Y; Suo X
    Eur J Haematol; 2024 Mar; 112(3):439-449. PubMed ID: 37950514
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PF4 activates the c-Mpl-Jak2 pathway in platelets.
    Buka RJ; Montague SJ; Moran LA; Martin EM; Slater A; Watson SP; Nicolson PLR
    Blood; 2024 Jan; 143(1):64-69. PubMed ID: 37883794
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Homeostatic cytokines reciprocally modulate the emergence of prenatal effector PLZF+CD4+ T cells in humans.
    Locher V; Park S; Bunis DG; Makredes S; Mayer M; Burt TD; Fragiadakis GK; Halkias J
    JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37856221
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R
    Parducci NS; Garnique ADMB; Lima K; Carlos JAEG; Fonseca NP; de Miranda LBL; de Almeida BO; Rego EM; Traina F; Machado-Neto JA
    Blood Cells Mol Dis; 2024 Jan; 104():102799. PubMed ID: 37839173
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting of stat5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression.
    Li J; Tang B; Miao Y; Li G; Sun Z
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37830151
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. stat5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia.
    Huang ZW; Zhang XN; Zhang L; Liu LL; Zhang JW; Sun YX; Xu JQ; Liu Q; Long ZJ
    Signal Transduct Target Ther; 2023 Sep; 8(1):391. PubMed ID: 37777506
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. XBP1 promotes NRAS
    Salimi A; Schemionek-Reinders M; Huber M; Vieri M; Patterson JB; Alten J; Brümmendorf TH; Kharabi Masouleh B; Appelmann I
    J Cell Mol Med; 2023 Nov; 27(21):3363-3377. PubMed ID: 37753803
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia.
    Ma H; Cui J; Liu Z; Fang W; Lu S; Cao S; Zhang Y; Chen JA; Lu L; Xie Q; Wang Y; Huang Y; Li K; Tong H; Huang J; Lu W
    Oncogene; 2023 Nov; 42(45):3331-3343. PubMed ID: 37752234
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 50.